Aggregated
50% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Wells Fargo
A Wells Fargo analyst with 6 tracked ratings across 6 distinct tickers has a 50% success rate on the captured sample, covering both sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| SGMO | 2024-12-31 | unknown | $2.00 | Aggregated |
| SGMOSANGAMO THERAPEUTICS INC | 2024-12-31 | unknown | $2.00 | Aggregated |
| RGLSREGULUS THERAPEUTICS INC | 2024-03-13 | unknown | $3.00 | Aggregated |
| CRSPCRISPR THERAPEUTICS AG | 2024-02-22 | unknown | $70.00 | Aggregated |
| ZYME | 2022-02-09 | buy | $48.00 | Aggregated |
| ZYMEZYMEWORKS BC INC | 2022-02-09 | unknown | $48.00 | Aggregated |
| ADAPADAPTIMMUNE THERAPEUTICS PLC - ADR | 2021-09-22 | unknown | $7.00 | Aggregated |
| ARRY | 2018-06-28 | buy | $33.00 | Aggregated |
| ZYME | 2018-06-04 | buy | $37.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| SGMO | 1 | 2024-12-31 | Aggregated |
| SGMOSANGAMO THERAPEUTICS INC | 1 | 2024-12-31 | Aggregated |
| RGLSREGULUS THERAPEUTICS INC | 1 | 2024-03-13 | Aggregated |
| CRSPCRISPR THERAPEUTICS AG | 1 | 2024-02-22 | Aggregated |
| ZYME | 2 | 2022-02-09 | Aggregated |
| ZYMEZYMEWORKS BC INC | 1 | 2022-02-09 | Aggregated |
| ADAPADAPTIMMUNE THERAPEUTICS PLC - ADR | 1 | 2021-09-22 | Aggregated |
| ARRY | 1 | 2018-06-28 | Aggregated |